<p>hMOF reduction enhances radiosensitivity through the homologous recombination pathway in non-small-cell lung cancer</p>

Abstract

Overexpression of hMOF predicts poor prognosis in patients with unresectable stage III NSCLC undergoing definitive RT. Downregulating hMOF might be a promising intervention to improve the outcome after RT.